Aditri Pharma Sciences Private Limited
About Aditri Pharma Sciences Private Limited
Data last updated:
Aditri Pharma Sciences Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG2019PTC138056. Its GSTIN is 36AATCA1162D1ZT (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kirthi Krishnan Gopi and Krishna Priya Dantuluri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P.No.3 Nr Aoc Center Shobhana Colony West Marredpally, Secunderabad, Telangana, India – 500026.
As per the financials filed for FY 2025, the company reported a revenue of ₹50.86 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.09 Cr (net margin -214.7%) and EBITDA of -₹1.08 Cr (EBITDA margin -213%). Revenue has grown at a compounded annual rate (CAGR) of 48% over three years and 18% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressP.No.3 Nr Aoc Center Shobhana Colony West Marredpally, Secunderabad, Telangana, India – 500026
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Aditri Pharma Sciences Private Limited
The main business activity of Aditri Pharma Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Aditri Pharma Sciences Private Limited FY 2025 filings available
Aditri Pharma Sciences Private Limited reported revenue of ₹50.86 Lakh (up 7706% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Aditri Pharma Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years. EBITDA fell 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aditri Pharma Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.08 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.09 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aditri Pharma Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -213% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -214.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aditri Pharma Sciences are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Aditri Pharma Sciences Private Limited
Aditri Pharma Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Impilo Pharmaceuticals Private Limited | ₹51.17 Lakh (FY 2019) | •••• | •••• | 20.0% | •••• | Bangalore, Karnataka, India |
| Seashell Laboratories Private Limited | ₹51.13 Lakh (FY 2018) | •••• | •••• | •••• | Dombivili West Thane, Maharashtra, India | |
| Mobanit Industries Private Limited | ₹51.1 Lakh (FY 2025) | •••• | •••• | 1773.0% | •••• | Salem, Tamil Nadu, India |
| Delizia Pharmaceutical Private Limited | ₹51.04 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Nallasopara East, Maharashtra, India |
| Spurt Pharmaceuticals Private Limited | ₹50.98 Lakh (FY 2024) | •••• | •••• | -19.0% | •••• | New Delhi, Delhi, India |
| Aditri Pharma Sciences Private Limited this company | ₹50.86 Lakh (FY 2025) | •••• | •••• | 7706.0% | •••• | Secunderabad, Telangana, India |
| Markecho Pharmaceuticals Private Limited | ₹50.83 Lakh (FY 2024) | •••• | •••• | 17.0% | •••• | Andheri, Mumbai, Maharashtra, India |
| Endear Pharma Private Limited | ₹50.81 Lakh (FY 2021) | •••• | •••• | 347.0% | •••• | Bijnor, Uttar Pradesh, India |
| Blismed Pharmaceuticals Private Limited | ₹50.79 Lakh (FY 2025) | •••• | •••• | -4.0% | •••• | Baddi, Himachal Pradesh, India |
| Serbia Molecules Private Limited | ₹50.76 Lakh (FY 2025) | •••• | •••• | -74.0% | •••• | Karnal, Haryana, India |
| Norfo Antibiotic Private Limited | ₹50.74 Lakh (FY 2025) | •••• | •••• | -22.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Aditri Pharma Sciences by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Aditri Pharma Sciences Private Limited
Aditri Pharma Sciences has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kirthi Krishnan Gopi Also directs: Sapsan Pharmaceuticals Private Limited | Director | 31 Dec 2019 | 6 Years 9 Months | Current |
| Krishna Priya Dantuluri | Director | 06 Dec 2024 | 1 Years 10 Months | Current |
| Gopi Krishnan Shivraj Also directs: Sapsan Pharmaceuticals Private Limited | Director | 06 Dec 2024 | 1 Years 10 Months | Current |
| Vijay Kumar Kumpatla | Director | 06 Dec 2024 | 1 Years 10 Months | Current |
| Satwick Reddy Vinta Also directs: NK Chemicals Pvt Ltd, Viplus Pharmaceuticals Private Limited | Director | 21 Nov 2025 | 0 Years 10 Months | Current |
Ownership and Shareholding of Aditri Pharma Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aditri Pharma Sciences Private Limited
Aditri Pharma Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Aditri Pharma Sciences Private Limited
Employment history and EPFO contributions of people linked to Aditri Pharma Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Aditri Pharma Sciences Private Limited
Aditri Pharma Sciences Private Limited has 6 board changes on record since 2019: 6 appointments. The latest: Satwick Reddy Vinta was appointed as Director on 21 Nov 2025.
Credit Ratings, Litigation & Regulatory Alerts for Aditri Pharma Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aditri Pharma Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aditri Pharma Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aditri Pharma Sciences Private Limited
Aditri Pharma Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AATCA1162D1ZT | Telangana | Active | 02 Mar 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aditri Pharma Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aditri Pharma Sciences Private Limited
Aditri Pharma Sciences is an active private limited company based in Secunderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 December 2019 (7+ years old) and is registered under CIN U51909TG2019PTC138056.
Aditri Pharma Sciences reported revenue of ₹50.86 Lakh for FY 2025 (up 7706% YoY).
Aditri Pharma Sciences has 5 current directors:
- Kirthi Krishnan Gopi - Director
- Krishna Priya Dantuluri - Director
- Gopi Krishnan Shivraj - Director
- Vijay Kumar Kumpatla - Director
- Satwick Reddy Vinta - Director
Aditri Pharma Sciences reported a net loss of ₹1.09 Cr (net margin -214.7%) and EBITDA of -₹1.08 Cr (EBITDA margin -213%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Aditri Pharma Sciences is -48% over three years and 18% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Aditri Pharma Sciences is 36AATCA1162D1ZT, registered in Telangana.
The CIN (Corporate Identification Number) of Aditri Pharma Sciences is U51909TG2019PTC138056. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aditri Pharma Sciences was incorporated on 31 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Aditri Pharma Sciences by revenue are Impilo Pharmaceuticals Private Limited, Seashell Laboratories Private Limited, Mobanit Industries Private Limited, Delizia Pharmaceutical Private Limited, Spurt Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Satwick Reddy Vinta was appointed as Director on 21 Nov 2025. Gopi Krishnan Shivraj was appointed as Director on 06 Dec 2024. Krishna Priya Dantuluri was appointed as Director on 06 Dec 2024. Aditri Pharma Sciences has 6 board changes on record in total.
The registered office of Aditri Pharma Sciences is at P.No.3 Nr Aoc Center Shobhana Colony West Marredpally, Secunderabad, Telangana, India – 500026.